Letter to the Editor: Liraglutide-Induced Increase in Bone Formation Can Be Dependent on Osteocalcin

J Clin Endocrinol Metab. 2015 Sep;100(9):L71. doi: 10.1210/jc.2015-2563.

Authors

Muhammed Kizilgul¹, Seyfullah Kan¹, Selvihan Beysel¹, Tuncay Delibasi¹

Affiliation

¹ Department of Endocrinology and Metabolism (M.K., S.B., T.D.), Diskapi Teaching and Research Hospital, Ankara, Turkey; Department of Endocrinology and Metabolism (S.K.), Ankara Teaching and Research Hospital, Ankara, Turkey; and Department of Internal Medicine (T.D.), School of Medicine (Kastamonu), Hacettepe University, Ankara, Turkey.

PMID: 26339737
DOI: 10.1210/jc.2015-2563

No abstract available

Publication types

Comment

MeSH terms

Bone Resorption / prevention & control*
Female
Glucagon-Like Peptide 1 / analogs & derivatives*
Humans
Obesity / drug therapy*
Osteogenesis / drug effects*
Receptors, Glucagon / agonists*
Weight Loss*

Substances

Receptors, Glucagon
Glucagon-Like Peptide 1